MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
SABS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SAB Biotherapeutics (SABS) Ownership - Who owns SAB Biotherapeutics?

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
777 West 41st Street
Phone
+1 305 845-2813
Employees
86
Web
https://www.sab.bio

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
259.21M
P/E Ratio
N/A
Total Cash
110.88M
Projected Growth
N/A
Total Debt
6.19M
Revenue
N/A
Risk (Beta)
-0.85
Dividend Yield
N/A
Total Cash/Share
1.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
SABS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for SABS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
777 West 41st Street
Phone
+1 305 845-2813
Employees
86
Web
https://www.sab.bio